HADH

Chr 4AR

hydroxyacyl-CoA dehydrogenase

Also known as: HAD, HADH1, HADHSC, HCDH, HHF4, MSCHAD, SCHAD

The protein catalyzes the third step of mitochondrial fatty acid beta-oxidation, specifically oxidizing medium and short-chain 3-hydroxy fatty acyl-CoAs, and also inhibits glutamate dehydrogenase to help regulate insulin secretion. Mutations cause 3-hydroxyacyl-CoA dehydrogenase deficiency and familial hyperinsulinemic hypoglycemia type 4, inherited in an autosomal recessive pattern. The gene shows extremely low constraint against loss-of-function variants (pLI 0.00007, LOEUF 0.998), indicating tolerance to complete protein loss.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 1.002 OMIM phenotypes
Clinical SummaryHADH
🧬
Gene-Disease Validity (ClinGen)
obsolete hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
32 unique Pathogenic / Likely Pathogenic· 84 VUS of 300 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — HADH
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.00LOEUF
pLI 0.000
Z-score 1.57
OE 0.57 (0.341.00)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.53Z-score
OE missense 0.89 (0.781.01)
163 obs / 183.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.57 (0.341.00)
00.351.4
Missense OE0.89 (0.781.01)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 9 / 15.7Missense obs/exp: 163 / 183.1Syn Z: -0.35
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveHADH-related 3-hydroxyacyl-CoA dehydrogenase deficiencyLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.76top 25%
GOF
0.5955th %ile
LOF
0.3162th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

300 submitted variants in ClinVar

Classification Summary

Pathogenic17
Likely Pathogenic15
VUS84
Likely Benign158
Benign19
Conflicting2
17
Pathogenic
15
Likely Pathogenic
84
VUS
158
Likely Benign
19
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
10
0
7
0
17
Likely Pathogenic
13
1
1
0
15
VUS
1
78
3
2
84
Likely Benign
0
1
84
73
158
Benign
0
0
19
0
19
Conflicting
2
Total248011475295

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

HADH · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →